Skip to main content
. 2019 Nov 13;7(1):e000774. doi: 10.1136/bmjdrc-2019-000774

Table 2.

ORs of adverse pregnancy outcomes by different glycemic markers

Quartile 1 Quartile 2 Quartile 3 Quartile 4 P for trend As continuous variables
FPG
 No of patients 502 494 494 486
 No of cases 182 194 217 296
 Model 1 1.00 1.13 (0.88–1.46) 1.37 (1.06–1.77) 2.70 (2.89–3.50) <0.001 2.40 (1.96–3.95)
 Model 2 1.00 1.19 (0.92–1.55) 1.40 (1.08–1.81) 2.57 (1.95–3.38) <0.001 2.32 (1.85–2.92)
1hPG
 No of patients 495 497 491 493
 No of cases 191 218 231 249
 Model 1 1.00 1.24 (0.96–1.60) 1.40 (1.09–1.80) 1.59 (1.23–2.05) 0.004 1.13 (1.07–1.20)
 Model 2 1.00 1.23 (0.95–1.59) 1.28 (0.99–1.67) 1.12 (0.81–1.55) 0.235 1.07 (1.01–1.15)
2hPG
 No of patients 499 494 490 493
 No of cases 203 206 227 253
 Model 1 1.00 1.04 (0.81–1.34) 1.24 (0.96–1.60) 1.50 (1.17–1.94) 0.006 1.11 (1.05–1.17)
 Model 2 1.00 1.01 (0.78–1.30) 1.17 (0.91–1.52) 1.05 (0.76–1.45) 0.591 1.03 (0.96–1.10)
HbA1c
 No of patients 609 517 443 407
 No of cases 248 216 192 233
 Model 1 1.00 1.04 (0.82–1.32) 1.10 (0.86–1.41) 1.91 (1.48–2.47) <0.001 1.99 (1.53–2.59)
 Model 2 1.00 1.03 (0.81–1.32) 1.07 (0.83–1.38) 1.72 (1.31–2.24) <0.001 1.77 (1.34–2.33)
1,5-AG
 No of patients 518 486 499 473
 No of cases 284 213 205 187
 Model 1 1.00 0.65 (0.51–0.84) 0.58 (0.45–0.74) 0.55 (0.42–0.70) <0.001 0.95 (0.93–0.97)
 Model 2 1.00 0.67 (0.52–0.86) 0.63 (0.49–0.81) 0.62 (0.47–0.81) <0.001 0.96 (0.94–0.98)

Model 1 adjusted for age.

Model 2 adjusted for age, body mass index, family history of diabetes, gestational complications, gestational age at oral glucose tolerance test, infant’s sex, and parities.

FPG, fasting plasma glucose.